These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3566189)
21. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links. Ross WE; Ewig RA; Kohn KW Cancer Res; 1978 Jun; 38(6):1502-6. PubMed ID: 565677 [TBL] [Abstract][Full Text] [Related]
22. Different activities of unscheduled DNA synthesis in human melanoma and bone marrow cells. Lewensohn R; Ringborg U; Hansson J Cancer Res; 1982 Jan; 42(1):84-8. PubMed ID: 7053870 [TBL] [Abstract][Full Text] [Related]
23. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo. Murray D; Jenkins WT; Meyn RE Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992 [TBL] [Abstract][Full Text] [Related]
24. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218 [TBL] [Abstract][Full Text] [Related]
25. Zinc-induced reduction in melphalan cytotoxicity: heterogeneity of response of cloned human tumor cells. Tobey RA; Tesmer JG; Shackelford ME J Cell Physiol; 1987 May; 131(2):235-9. PubMed ID: 3584249 [TBL] [Abstract][Full Text] [Related]
26. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78. Chatterjee S; Hirota H; Belfi CA; Berger SJ; Berger NA Cancer Res; 1997 Nov; 57(22):5112-6. PubMed ID: 9371511 [TBL] [Abstract][Full Text] [Related]
27. In-transit melanoma: the role of alkylating-agent resistance in regional therapy. Grubbs EG; Abdel-Wahab O; Cheng TY; Abdel-Wahab Z; Peterson B; Pruitt SK; Colvin OM; Friedman HS; Tyler DS J Am Coll Surg; 2004 Sep; 199(3):419-27. PubMed ID: 15325612 [TBL] [Abstract][Full Text] [Related]
28. Effect of hyperthermia on the formation and removal of DNA interstrand cross-links induced by melphalan in primary cultures of human malignant melanoma. Zaffaroni N; Villa R; Orlandi L; Vaglini M; Silvestrini R Int J Hyperthermia; 1992; 8(3):341-9. PubMed ID: 1607739 [TBL] [Abstract][Full Text] [Related]
29. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285 [TBL] [Abstract][Full Text] [Related]
30. Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione. Ali-Osman F Cancer Res; 1989 Oct; 49(19):5258-61. PubMed ID: 2766294 [TBL] [Abstract][Full Text] [Related]
31. Cis-diamminedichloroplatinum(II) toxicity in human melanoma cells and lymphocytes as related to cellular platinum accumulation, DNA cross-linking and inhibition of DNA synthesis. Hansson J; Lewensohn R; Ringborg U Acta Oncol; 1988; 27(4):383-92. PubMed ID: 3202996 [TBL] [Abstract][Full Text] [Related]
32. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194 [TBL] [Abstract][Full Text] [Related]
33. Direct measurement of melphalan conjugation with glutathione: studies with human melanoma cells and mammalian liver. Guenthner TM; Whalen R; Jevtović-Todorović V J Pharmacol Exp Ther; 1992 Mar; 260(3):1331-6. PubMed ID: 1545395 [TBL] [Abstract][Full Text] [Related]
34. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells. Parsons PG; Morrison LE Cancer Res; 1982 Sep; 42(9):3783-8. PubMed ID: 6809313 [TBL] [Abstract][Full Text] [Related]
35. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity. Robson CN; Lewis AD; Wolf CR; Hayes JD; Hall A; Proctor SJ; Harris AL; Hickson ID Cancer Res; 1987 Nov; 47(22):6022-7. PubMed ID: 3664506 [TBL] [Abstract][Full Text] [Related]
36. Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. Hartley JM; Spanswick VJ; Gander M; Giacomini G; Whelan J; Souhami RL; Hartley JA Clin Cancer Res; 1999 Mar; 5(3):507-12. PubMed ID: 10100700 [TBL] [Abstract][Full Text] [Related]
37. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity. Schecter RL; Alaoui-Jamali MA; Woo A; Fahl WE; Batist G Cancer Res; 1993 Oct; 53(20):4900-6. PubMed ID: 8402679 [TBL] [Abstract][Full Text] [Related]
38. Melphalan-induced DNA damage in p53(+/-) and wild type mice analysed by the comet assay. Cordelli E; Cinelli S; Lascialfari A; Ranaldi R; Pacchierotti F Mutat Res; 2004 Jun; 550(1-2):133-43. PubMed ID: 15135647 [TBL] [Abstract][Full Text] [Related]
39. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing. Szmigiero L; Erickson LC; Ewig RA; Kohn KW Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Erickson LC; Ramonas LM; Zaharko DS; Kohn KW Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]